eplerenone
Showing 1 - 25 of 164
Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta
Completed
- Central Serous Chorioretinopathy
- Eplerenone , Intravitreal Aflibercept and Topical nepafenac therapy
-
Cairo, EgyptKasr alainy faculty of medicine
May 5, 2023
Bioequivalence, Healthy Subjects Trial in Amman (Efez 50 mg eplerenone film-coated tablets, INSPRA® 50 mg eplerenone film-coated
Completed
- Bioequivalence
- Healthy Subjects
- Efez 50 mg eplerenone film-coated tablets
- INSPRA® 50 mg eplerenone film-coated tablets
-
Amman, JordanACDIMA Center for Bioequivalence and Pharmaceutical Studies
Dec 15, 2022
Quality of Life and Clinical parameterS in paTients With chronIc
Not yet recruiting
- Chronic Heart Failure
- Eplerenone torasemide in chronic heart failure
- (no location specified)
Oct 31, 2023
Kidney Transplantation for More Than One Year, Patients With a Kidney Transplantation on Cyclosporine Trial in
Recruiting
- Kidney Transplantation for More Than One Year
- Patients With a Kidney Transplantation on Cyclosporine
- Eplerenone 50mg/day (cross over design)
- Period without eplerenone (cross over design)
-
Vandœuvre-lès-Nancy, FranceCHRU de Nancy
Aug 17, 2022
Degenerative Intervertebral Discs, Sciatic Radiculopathy, Low Back Pain Trial in Cincinnati, West Chester (Eplerenone 50 Mg Tab,
Recruiting
- Degenerative Intervertebral Discs
- +2 more
- Eplerenone 50 Mg Tab
- Placebo Oral Tablet
-
Cincinnati, Ohio
- +1 more
May 19, 2022
HIV Trial in Boston (Eplerenone, Placebo, Lifestyle Modification)
Completed
- HIV
- Eplerenone
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Jul 14, 2022
Hypertension Trial in Ann Arbor (Placebo, Eplerenone 50mg)
Not yet recruiting
- Hypertension
- Placebo
- Eplerenone 50mg
-
Ann Arbor, MichiganUniversity of Michigan
Feb 4, 2022
Heart Failure, Type 2 Diabetes, Glucose Intolerance Trial in Montreal (Eplerenone, Spironolactone)
Completed
- Heart Failure
- +2 more
- Eplerenone
- Spironolactone
-
Montreal, Quebec, CanadaMontreal Heart Institute
Oct 5, 2022
Eplerenone Versus PDT: Comparative Study by OCTA
Completed
- Central Serous Chorioretinopathy
- Eplerenone
- The patients underwent half fluence photodynamic therapy for 6 months
- (no location specified)
Oct 21, 2021
Primary Hyperaldosteronism Due to Adrenal Adenoma Trial in Gothenburg, Stockholm, Umeå (Unilateral adrenalectomy, Medical
Not yet recruiting
- Primary Hyperaldosteronism Due to Adrenal Adenoma
- Unilateral adrenalectomy
- Medical treatment (eplerenone)
-
Gothenburg, Sweden
- +2 more
Mar 30, 2023
Cardiomyopathy Trial in London (Eplerenone, Placebo)
Completed
- Cardiomyopathy
- Eplerenone
- Placebo
-
London, United KingdomRoyal Brompton & Harefield NHS Trust
Sep 14, 2021
Hypertension, Mineralocorticoid Excess Trial in Boston (Eplerenone, Amlodipine)
Recruiting
- Hypertension
- Mineralocorticoid Excess
- Eplerenone
- Amlodipine
-
Boston, MassachusettsBrigham and Women's
Jul 20, 2022
Systolic Heart Failure Trial in Copenhagen (Eplerenone, Spironolactone)
Enrolling by invitation
- Systolic Heart Failure
- Eplerenone
- Spironolactone
-
Copenhagen, DenmarkBispebjerg Hospital
Aug 9, 2021
HF - Heart Failure, Diabetes Trial in Chicago (Bumetanide 0.5 mg, dapaglifozin 5 mg, eplerenone 25 mg)
Withdrawn
- HF - Heart Failure
- Diabetes Mellitus
- Bumetanide 0.5 mg, dapaglifozin 5 mg, eplerenone 25 mg
-
Chicago, IllinoisNorthwestern University
May 4, 2022
Metabolic Syndrome, Hypertension, Overweight and Obesity Trial in Boston (Eplerenone, Chlorthalidone with potassium chloride)
Recruiting
- Metabolic Syndrome
- +2 more
- Eplerenone
- Chlorthalidone with potassium chloride
-
Boston, MassachusettsBrigham and Women's Hospital
Feb 28, 2022
Clinical Pharmacology Trial in Neuss (Finerenone (BAY 94-8862) PEG solution, Finerenone (BAY 94-8862) immediate release tablet,
Completed
- Clinical Pharmacology
- Finerenone (BAY 94-8862) PEG solution
- +3 more
-
Neuss, Nordrhein-Westfalen, Germany(unnamed)
Jan 27, 2022
Phospholamban R14del Mutation-related Cardiomyopathy Trial in Netherlands (Eplerenone)
Completed
- Phospholamban R14del Mutation-related Cardiomyopathy
- Eplerenone
-
Sneek, Friesland, Netherlands
- +3 more
Oct 15, 2021
Essential Hypertension Trial in East Hanover (LCI699, Eplerenone, LCI699-matching Placebo)
Completed
- Essential Hypertension
- LCI699
- +3 more
-
East Hanover, New JerseyNovartis Pharmaceuticals
Jun 11, 2021
Hypertension, Left Ventricular Hypertrophy Trial (Eplerenone, Chlorthalidone, Potassium)
Not yet recruiting
- Hypertension
- Left Ventricular Hypertrophy
- Eplerenone
- +2 more
- (no location specified)
Oct 26, 2022
Primary Hyperparathyroidism Trial in Boston (eplerenone, amiloride, Placebo)
Completed
- Primary Hyperparathyroidism
- eplerenone
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 26, 2021
Vitreomacular Traction, Subretinal Edema Trial in Norfolk (Eplerenone)
Terminated
- Vitreomacular Traction
- Subretinal Edema
- Eplerenone
-
Norfolk, VirginiaWagner Macula & Retina Center
Jan 6, 2021
Hypertension, Genetics Hypertension Trial in Boston (Eplerenone vs Amlodipine)
Recruiting
- Hypertension
- Genetics Hypertension
- Eplerenone vs Amlodipine
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 11, 2021
Hypertension Trial in Dallas (Eplerenone, Amlodipine, Microneurography)
Completed
- Hypertension
- Eplerenone
- +7 more
-
Dallas, TexasUT Southwestern Medical Center
Feb 22, 2022
Primary Aldosteronism, Hypertension Trial (Eplerenone)
Not yet recruiting
- Primary Aldosteronism
- Hypertension
- Eplerenone
- (no location specified)
Aug 26, 2021